These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5982902)

  • 1. [Antibody level and antibody spectrum following vaccination of man with polyvalent adsorbed influenza vaccines].
    Ricken D; Oberhoffer G; Heinen H; Posch J
    Med Klin; 1966 Jan; 61(3):92-6. PubMed ID: 5982902
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influenza vaccination and antibody development in man].
    Potel J
    Med Klin; 1966 Jan; 61(3):87-91. PubMed ID: 5982901
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antigenicity of various influenza vaccines in man].
    Kuwert E; Höhner PG; Bertrams J; Schriever O
    Dtsch Med Wochenschr; 1971 May; 96(22):938-45. PubMed ID: 4325348
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibody development in influenza vaccination with a polyvalent aluminum oxide adsorbed vaccine].
    Dorow P
    Ther Ggw; 1975 Nov; 114(11):1934-44. PubMed ID: 1209511
    [No Abstract]   [Full Text] [Related]  

  • 5. Antineuraminidase antibody response of man to influenza virus neuraminidase N2: results obtained with an improved hemagglutination inhibition technique and an enzyme inhibition test.
    Hennessy AV; Minuse E; Davenport FM
    J Immunol; 1972 Aug; 109(2):213-6. PubMed ID: 5047368
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serological studies in preventive influenza vaccinations with aluminum oxide-adsorbed polyvalent vaccines].
    Gerth HJ
    Z Hyg Infektionskr; 1965 Dec; 151(4):311-25. PubMed ID: 5869207
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of thymus extract TP on antibody formation in rats irradiated and immunized with influenza vaccine, strain A2].
    Milcu SM; Boeru V; Babeş V; Panaitiu G; Potop I
    Stud Cercet Endocrinol; 1973; 24(6):483-9. PubMed ID: 4769475
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody formation after vaccination with adsorbed and non-adsorbed A/New Jersey/8/76 influenza vaccines.
    Schenk KD; Pressler K; Sarateanu DE; Peukert M; Ehrengut W; Schnitker J
    Pharmatherapeutica; 1982; 3(3):201-8. PubMed ID: 7134228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative antigenic potency in man of polyvalent influenza virus vaccines containing isolated hemagglutinins or intact viruses.
    Hennessy AV; Davenport FM
    J Immunol; 1966 Aug; 97(2):235-8. PubMed ID: 5921312
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibody formation in pulmonary tuberculosis patients following protective inoculation against influenza virus].
    Grassl E
    Med Klin; 1966 Feb; 61(8):288-90. PubMed ID: 4860852
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study.
    Brydak LB; Romanowska M; Nowak I; Ciszewski A; Bilińska ZT
    Med Sci Monit; 2009 Jul; 15(7):PH85-91. PubMed ID: 19564837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.
    Iorio AM; Camilloni B; Basileo M; Neri M; Lepri E; Spighi M
    Gerontology; 2007; 53(6):411-8. PubMed ID: 17975317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effectiveness of influenza inoculation. Serological testing of a polyvalent vaccine containing Hongkong A2 serum].
    Röllinghoff M; Schäfer E
    Munch Med Wochenschr; 1970 Nov; 112(48):2178-82. PubMed ID: 5536877
    [No Abstract]   [Full Text] [Related]  

  • 15. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines.
    Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
    Am J Dis Child; 1982 Jun; 136(6):513-7. PubMed ID: 7046421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune response to influenza virus. I. Effect of the route and schedule of vaccination on the time course of the immune response, as measured by three serological methods.
    Webster RG
    Immunology; 1965 Dec; 9(6):501-19. PubMed ID: 5853072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the reactogenic and immunogenic properties of the influenza subunit polyvalent vaccine Grippovac SE-AZh during the immunization of schoolchildren].
    Slepushkin AN; Obrosova-Serova NP; Feklisova LV; Bebisheva NI; Mel'nikova SK
    Vestn Akad Med Nauk SSSR; 1984; (1):75-9. PubMed ID: 6711101
    [No Abstract]   [Full Text] [Related]  

  • 18. [The antibody level against influenza viruses in man during the course of immunization with TAB vaccines].
    GERTH HJ; WUNDT W
    Z Immun exp ther; 1962 Dec; 124():370-81. PubMed ID: 13947383
    [No Abstract]   [Full Text] [Related]  

  • 19. The antigenic subunits of influenza viruses. I. The homologous antibody response.
    Fazekas de Saint Groth ; Webster RG; Davenport FM
    J Immunol; 1969 Nov; 103(5):1099-106. PubMed ID: 5350969
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibody response to trivalent anti-influenza vaccination (inactivated virus) A/Texas/1/77 H3N2), A/URSS/90/77 (H1N1), B/Hong Kong/8/73].
    Mancini G; Andreoni M; Arangio-Ruiz G; Sarrecchia C; Donatelli I; Resta S; Rozera C; Sordillo P; Rocchi G
    Boll Ist Sieroter Milan; 1982 May; 61(2):85-91. PubMed ID: 7126342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.